Composition
    1.
    发明授权
    Composition 失效
    组成

    公开(公告)号:US5843876A

    公开(公告)日:1998-12-01

    申请号:US790637

    申请日:1997-01-29

    IPC分类号: C11D3/20 C11D9/04

    摘要: A cleansing composition which comprises a cleansing effective amount of a long chain alkyl or alkenyl containing surfactant or mixtures thereof and a color stabilizing effective amount of a compound selected from the group consisting of ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7 and R.sub.8 are the same or different and are isopropyl or tertiary butyl, ##STR2## wherein R.sub.9 and R.sub.10 are the same or different and are isopropyl or tertiary butyl and n is about 8 to about 20, or ##STR3## wherein R.sub.11, R.sub.12, R.sub.13, R.sub.14, R.sub.15 and R.sub.16 are the same or different and are isopropyl or tertiary butyl.

    摘要翻译: 一种清洁组合物,其包含清洁有效量的含有长链烷基或烯基的表面活性剂或其混合物和稳定颜色的有效量的选自以下的化合物:a。 其中R 1,R 2,R 3,R 4,R 5,R 6,R 7和R 8相同或不同,为异丙基或叔丁基。 其中R9和R10相同或不同,为异丙基或叔丁基,n为约8至约20,或者为。 其中R11,R12,R13,R14,R15和R16相同或不同,为异丙基或叔丁基。

    Composition
    2.
    发明授权
    Composition 失效
    组成

    公开(公告)号:US5840670A

    公开(公告)日:1998-11-24

    申请号:US790498

    申请日:1997-01-29

    IPC分类号: C11D3/28 C11D9/30

    CPC分类号: C11D3/28 C11D9/30

    摘要: A cleansing composition which comprises a cleansing effective amount of one or a mixture of a surfactant and a color stabilizing effective amount of a compound of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are the same or different and are isopropyl or tertiary butyl.

    摘要翻译: 一种清洁组合物,其包含清洁有效量的一种或其表面活性剂和稳定颜色的有效量的下式化合物的混合物,其中R 1,R 2,R 3,R 4,R 5和R 6相同或不同, 是异丙基或叔丁基。

    Implant for intraocular drug delivery
    10.
    发明申请
    Implant for intraocular drug delivery 审中-公开
    植入物用于眼内药物递送

    公开(公告)号:US20060110429A1

    公开(公告)日:2006-05-25

    申请号:US11280377

    申请日:2005-11-16

    IPC分类号: A61K39/395 A61F2/00

    摘要: An implant for intraocular drug delivery for the treatment of inflammatory or degenerative diseases. In one embodiment, the implant includes a body portion having a first end portion and a second, opposite end portion and defining a cavity with a first opening at the first end portion, and a second, opposite opening at the second end portion, and a solid material received in the cavity, wherein the solid material comprises a depot material and an effective amount of at least one therapeutic compound or agent. When the implant is implanted in an eye of a living subject, the effective amount of at least one therapeutic compound or agent is released to the environment of the implant through at least one of the first opening and the second, opposite opening over an extended period of time.

    摘要翻译: 用于眼内药物递送的植入物用于治疗炎性或退行性疾病。 在一个实施例中,植入物包括具有第一端部和第二相对端部并且在第一端部处限定具有第一开口的空腔的主体部分和在第二端部处的第二相对的开口, 容纳在空腔中的固体材料,其中固体材料包含贮库材料和有效量的至少一种治疗化合物或药剂。 当植入物植入生物体的眼睛中时,至少一种治疗化合物或药剂的有效量通过第一开口和第二相对开口中的至少一个在延长的时间段内释放到植入物的环境中 的时间。